A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis

AIMS: To examine the efficacy of tacrolimus ophthalmic suspension 0.1% in treating severe allergic conjunctivitis. METHODS: This was a multicenter, randomized, double-masked, placebo-controlled clinical trial. Fifty-six patients with severe allergic conjunctivitis in whom topical antiallergic agents...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ohashi, Yuichi, Ebihara, Nobuyuki, Fujishima, Hiroshi, Fukushima, Atsuki, Kumagai, Naoki, Nakagawa, Yayoi, Namba, Kenichi, Okamoto, Shigeki, Shoji, Jun, Takamura, Etsuko, Hayashi, Kunihiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. publishers 2010
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158389/
https://ncbi.nlm.nih.gov/pubmed/20307214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2009.0087
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller